Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
暂无分享,去创建一个
E. Lander | T. Golub | C. Huard | M. Loh | J. Downing | F. Behm | S. Raimondi | C. Pui | A. Ferrando | D. Neuberg | J. Staunton | D. Gilliland | A. Look | Ching-Hon Pui | Susana C. Raimondi | A. Look | M. Loh
[1] R. Heilig,et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia , 2001, Leukemia.
[2] M. Cybulsky,et al. Positive Regulation of T Cell Activation and Integrin Adhesion by the Adapter Fyb/Slap , 2001, Science.
[3] Yoji Shimizu,et al. Coupling of the TCR to Integrin Activation by SLAP-130/Fyb , 2001, Science.
[4] C. Murre,et al. Early Thymocyte Development Is Regulated by Modulation of E2a Protein Activity , 2001, The Journal of experimental medicine.
[5] C. Rudd,et al. Adaptor FYB (Fyn-binding protein) regulates integrin-mediated adhesion and mediator release: Differential involvement of the FYB SH3 domain , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Rolink,et al. Within the hemopoietic system, LAR phosphatase is a T cell lineage‐specific adhesion receptor‐like protein whose phosphatase activity appears dispensable for T cell development, repertoire selection and function , 2001, European journal of immunology.
[7] R. Gelber,et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. , 2001, Blood.
[8] P. Burton,et al. Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. , 2001, Blood.
[9] I. Bernstein,et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. , 2001, Blood.
[10] C. Roberts,et al. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Teng,et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. , 2000, Cancer research.
[12] T. Hoang,et al. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression , 2000, Nature Immunology.
[13] C. Murre. Intertwining proteins in thymocyte development and cancer , 2000, Nature Immunology.
[14] W. Hiddemann,et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. , 2000, Blood.
[15] P. D. de Jong,et al. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Korsmeyer,et al. Rnx deficiency results in congenital central hypoventilation , 2000, Nature Genetics.
[17] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[18] A. Look,et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study , 1999, Leukemia.
[19] S. Levy,et al. Expression of the Bcl-2 family member A1 is developmentally regulated in T cells. , 1999, International immunology.
[20] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[21] K. Gross,et al. Disordered T-Cell Development and T-Cell Malignancies in SCL LMO1 Double-Transgenic Mice: Parallels with E2A-Deficient Mice , 1999, Molecular and Cellular Biology.
[22] A. Green,et al. The SCL gene: from case report to critical hematopoietic regulator. , 1999, Blood.
[23] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Lees,et al. Cyclin E Associates with BAF155 and BRG1, Components of the Mammalian SWI-SNF Complex, and Alters the Ability of BRG1 To Induce Growth Arrest , 1999, Molecular and Cellular Biology.
[25] J. Downing,et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] B. Haynes,et al. Developmental regulation of lymphocyte-specific protein 1 (LSP1) expression in thymus during human T-cell maturation. , 1998, Hybridoma.
[27] T. Hawley,et al. Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential. , 1998, Blood.
[28] Olivier Delattre,et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.
[29] H. Drexler. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells , 1998, Leukemia.
[30] J. Ashwell,et al. A Positive Role for Thymus‐Derived Steroids in Formation of the T‐Cell Repertoire , 1998, Annals of the New York Academy of Sciences.
[31] Xiao-Hong Sun,et al. The Tal1 Oncoprotein Inhibits E47-mediated Transcription , 1998, The Journal of Biological Chemistry.
[32] H. Fehling,et al. Molecular and cellular events in early thymocyte development. , 1998, Advances in immunology.
[33] R. Benezra,et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice , 1997, Molecular and cellular biology.
[34] L. Wodicka,et al. Genome-wide expression monitoring in Saccharomyces cerevisiae , 1997, Nature Biotechnology.
[35] A T Look,et al. Oncogenic transcription factors in the human acute leukemias. , 1997, Science.
[36] T. Naoe,et al. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines , 1997, Leukemia.
[37] D. Pinkel,et al. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas , 1997, Molecular and cellular biology.
[38] T. Rabbitts,et al. The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI proteins , 1997, The EMBO journal.
[39] D L Black,et al. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. , 1997, Genes & development.
[40] S. Korsmeyer,et al. HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint , 1997, Nature.
[41] N. Zhang,et al. Transforming function of the HOX11/TCL3 homeobox gene. , 1997, Cancer research.
[42] H. Kaneko,et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. , 1996, Leukemia.
[43] C. Croce,et al. Advances in Brief T-Cell . . directed TAL-1 Expression Induces T-Cell Malignancies in Transgenic Mice ' , 2006 .
[44] P. Leder,et al. Tal‐1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. , 1996, The EMBO journal.
[45] J. Downing,et al. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. , 1996, Blood.
[46] M. Cleary,et al. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells , 1996, Molecular and cellular biology.
[47] J. Downing,et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. , 1996, Blood.
[48] T. Rabbitts,et al. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. , 1996, The EMBO journal.
[49] John Calvin Reed. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. , 1995, Current opinion in oncology.
[50] J. Rehg,et al. Ectopic expression of rhombotin-2 causes selective expansion of CD4-CD8- lymphocytes in the thymus and T-cell tumors in transgenic mice. , 1995, Blood.
[51] A Orfao,et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.
[52] M. Sofroniew,et al. The Hox11 gene is essential for cell survival during spleen development. , 1995, Development.
[53] M. Amylon,et al. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. , 1995, Blood.
[54] F. Alt,et al. Bclx regulates the survival of double-positive thymocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[55] S. Shurtleff,et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. , 1995, Blood.
[56] C. C. Bailey,et al. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X , 1995, The Lancet.
[57] J. Li,et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. , 1994, The EMBO journal.
[58] J. Li,et al. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[59] T. Langford,et al. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. , 1994, Oncogene.
[60] S. Korsmeyer,et al. Hox11 controls the genesis of the spleen , 1994, Nature.
[61] H. Hsu,et al. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. Baer. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. , 1993, Seminars in cancer biology.
[63] S. Korsmeyer,et al. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. , 1993, Journal of immunology.
[64] H. Spits,et al. Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development , 1993, The Journal of experimental medicine.
[65] G. Sclar,et al. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma , 1992, Molecular and cellular biology.
[66] H. Sather,et al. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. , 1992, Blood.
[67] L. Picker,et al. Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow. , 1992, Blood.
[68] R. Espinosa,et al. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[69] S. Kamel‐Reid,et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) , 1991 .
[70] S. Raimondi,et al. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). , 1991, Blood.
[71] I. Kirsch,et al. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia , 1991, Molecular and cellular biology.
[72] T. Rabbitts,et al. HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[73] W. Ludwig,et al. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). , 1991, Oncogene.
[74] M. Lu,et al. The tcl‐3 proto‐oncogene altered by chromosomal translocation in T‐cell leukemia codes for a homeobox protein. , 1991, The EMBO journal.
[75] R. Berger,et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene. , 1991, Oncogene.
[76] S. Korsmeyer,et al. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.
[77] E. Turley,et al. FMC46, a cell protrusion-associated leukocyte adhesion molecule-1 epitope on human lymphocytes and thymocytes. , 1991, Journal of immunology.
[78] M. Perutz,et al. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[79] F. Behm,et al. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy , 1991, The Lancet.
[80] I. Kirsch,et al. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. , 1990, Science.
[81] M. Siciliano,et al. Site‐specific recombination of the tal‐1 gene is a common occurrence in human T cell leukemia. , 1990, The EMBO journal.
[82] M. Surani,et al. Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system , 1990, Nature.
[83] A. Carroll,et al. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. , 1990, The EMBO journal.
[84] R. Berger,et al. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T‐cell leukemias , 1990, Genes, chromosomes & cancer.
[85] M. Cleary,et al. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif , 1989, Cell.
[86] P. Nowell,et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[87] S. Korsmeyer,et al. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein , 1989, Molecular and cellular biology.
[88] T. Waldmann,et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[89] Ellis L. Reinherz,et al. The differentiation and function of human T lymphocytes , 1980, Cell.